Dose coefficients based on the recommendations of International Commission on Radiological Protection (ICRP) Publication 103 were reported in ICRP Publication 116, the revision of ICRP Publication 74 and ICRU Publication 57 for the six reference irradiation geometries: anterior-posterior, posterior-anterior, right and left lateral, rotational and isotropic. In this work, dose coefficients for neutron irradiation of the body with parallel beams directed upward from below the feet (caudal) and downward from above the head (cranial) using the ICRP 103 methodology were computed using the MCNP 6.1 radiation transport code. The dose coefficients were determined for neutrons ranging in energy from 10 -9 MeV to 10 GeV. At energies below about 500 MeV, the cranial and caudal dose coefficients are less than those for the six reference geometries reported in ICRP Publication 116.
INTRODUCTION
The International Commission on Radiological Protection (ICRP) DOCAL task group reported effective and tissue equivalent dose conversion coefficients (hereafter referred to as dose coefficients) in ICRP Publication 116 (1) which replaced those recommended in ICRP Publication 74 (2) and the International Commission on Radiation Units and Measurements Report 57 (3) . The dose coefficients reported in ICRP Publication 116 were determined using the methodology prescribed in ICRP Publication 103 (4) for the six standard irradiation geometries (anterior-posterior (AP), posterior-anterior (PA), right and left lateral (RLAT and LLAT), rotational (ROT) and isotropic (ISO)) using the male and female ICRP reference voxel phantoms defined in ICRP Publication 110 (5) . In a recent publication (6) , photon dose coefficients for cranial (parallel beams directed downward from above the head) and caudal (directed upward from below the feet) geometries using the ICRP methodologies were reported by the authors. In this paper, similar dose coefficient calculations performed for neutrons are reported.
The AP and ISO geometries are typically used in radiation protection programs. In many practical situations, the standard geometries may not be the most appropriate or representative of personnel exposures. In particular, the irradiation geometries of ICRP 116 do not account for the possibility of a person being exposed by sources either beneath the feet (caudal) or overhead (cranial) (see Figure 1) . In operational settings, personnel may perform work on contaminated surfaces or with sources positioned overhead. Because the effective dose is dependent upon the doses delivered to organs and tissues, and since these organs and tissues are located throughout the body, the caudal (CAU) and cranial (CRA) geometries may result in significantly different effective doses compared with the six geometries addressed in ICRP 116.
MATERIALS AND METHODS

Protection quantity calculations
Under the ICRP 103 methodology, the organ and tissue absorbed dose coefficients are determined for the male and female reference voxel phantoms separately, the appropriate radiation weighting factor applied, then sex-averaged equivalent dose coefficients obtained by averaging the values from the male and female phantoms. In ICRP 103, the radiation weighting factor, w R , for neutrons is dependent on the neutron energy incident on the phantom and ICRP 103 provides a continuous function for the neutron w R for energy regions as listed in Table 1 . Once the sex-averaged equivalent doses are determined, they are weighted by the organ and tissue weighting factors and summed to determine the effective dose coefficient. In the ICRP 103 methodology, the specific organs used to define the remainder are prescribed.
ICRP Publication 103 defines effective dose, E, as
where H M T is the equivalent dose to organ T of the male phantom, H F T is the equivalent dose to organ T of the female phantom and w T is the organ or tissue weighting factor. The equivalent dose to the organ or tissue is
where w R is the radiation weighting factor and D T R , is the absorbed dose to tissue or organ T from incident radiation R.
Reference phantoms
The reference phantoms of ICRP 110 (5) were used for all calculations along with tissue compositions and densities based on ICRP 89 (7) . Because of the voxel resolution, calculations to sensitive regions of the skin (e.g. a depth of 0.07 mm) and to the lens of the eye are not possible; nonetheless, for the calculations reported herein the dose to those voxels defining the skin was used. Lens of the eye dose coefficients are not reported here.
Reference radiation field orientations
For caudal and cranial calculations, planar monoenergetic neutron sources were oriented either below the feet or over the head with particles directed parallel to the long axis of the phantom. Source areas were sufficiently large to ensure the entire cross-sectional area of the phantom was within the radiation field.
Calculational method
Calculations were performed using the MCNP 6.1 (8) radiation transport code along with ENDF-B/VII cross-sections. The cascade-exciton model (CEM) was employed at neutron energies above the upper range of the cross-section tables (150 MeV). The phantoms from ICRP Publication 110 were modeled and irradiated with the planar sources in a vacuum. Absorbed doses to organs were calculated and secondary particles (both charged and uncharged) were tracked until their energies reached the default cutoff energies of MCNP which are listed in Table 2 . Dose coefficients were computed for the set of neutron energies used in ICRP Publication 116 ranging from 10 -9 MeV to 10 GeV. Organ equivalent dose and effective dose coefficients were normalized to particle fluence and are presented in units of pSv cm 2 . Because of the segmentation of the cortical (bone surface) and spongiosa (red bone marrow) regions, these doses were tallied individually and mass weighted to determine the total bone surface and red bone marrow doses. This method is in accordance with that used for ICRP Publication 116 dose coefficients. Table 2 . Default particle cutoff energies in MCNP 6.1 (8) . Tally uncertainties were minimized, although some organs that received small doses had larger tally uncertainties. In cases where these organs and tissues did not significantly contribute to the effective dose, this uncertainty was accepted as a practical limitation on computation time. When the organs or tissues were significant contributors to effective dose (the weighted organ equivalent dose, w T H T , was greater than 1% of the effective dose), additional particle histories were executed to reduce the organ absorbed dose uncertainty to below 3%. In the cases of the bone surface and the red bone marrow, the contributor tally errors were propagated using mass weighting. The effective dose error was determined by propagating the sex-averaged, organ-weighted equivalent doses in quadrature.
Particle
RESULTS AND DISCUSSION
Effective dose coefficients for cranial (CRA) and caudal (CAU) exposures are shown in Figure 2 along with AP and ISO irradiation geometry values from ICRP Publication 116. Tabulated results of effective dose for caudal and cranial geometries are listed in Table 3 . Tables for all organs Figure 3 .
To demonstrate the impact of CRA and CAU orientations on organ dose, the coefficients for the sexaveraged brain are shown in Figure 4 for CRA, CAU, AP and ISO irradiations. While doses to the brain from CAU exposures are smaller at most energies, they exceed the values for other geometries above about 2 GeV because of secondary particle production effects. A close examination of the dose coefficients shows a step change for both the CRA and CAU orientations at 150 MeV. This change is a result of the switch from library cross-sections to the CEM within the MCNP code.
CONCLUSION
Dose coefficients for caudal and cranial irradiation geometries have been calculated in accordance with ICRP Publication 103. The coefficients differ significantly from AP and ISO values of ICRP Publication 116, as would be expected. For workers irradiated in these geometries, organ and effective doses can differ significantly from the standard geometries. For the neutron energies encountered at most nuclear facilities (i.e. thermal to a few MeV), the AP and ISO effective dose overestimates the caudal and cranial values. Above~500 MeV, the CRA and CAU effective dose is underestimated by the six reference geometries reported in ICRP Publication 116.
